Inhibikase TherapeuticsIKT
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 47 institutions reported holding Inhibikase Therapeutics Inc. (IKT) in their 13F filings, up 16 from Q4 2024. 19 opened new positions and 3 sold out. The largest holders were Sands Capital Alternatives, LLC ($24.0M), Soleus Capital Management, L.P. ($13.9M) and Fairmount Funds Management LLC ($13.4M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Inhibikase Therapeutics Inc.
- CUSIP
- 45719W205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 19 | $2.6M |
| Exits | 3 | $141K |
All 13F filers, Q4 2024 → Q1 2025: 2,296,069 shares bought and 892,621 shares sold, net +1,403,448 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| Sands Capital Alternatives, LLC | 5.86% | No change | 10,950,000 | $24.0M |
| Soleus Capital Management, L.P. | 1.09% | No change | 6,325,000 | $13.9M |
| Fairmount Funds Management LLC | 2.08% | No change | 6,125,000 | $13.4M |
| Perceptive Advisors LLC | 0.46% | No change | 5,925,000 | $13.0M |
| Commodore Capital LP | 0.86% | Reduce -9.8% | 5,344,432 | $11.7M |
| ADAR1 Capital Management, LLC | 2.22% | Add +0.4% | 5,122,105 | $11.2M |
| Vanguard Group Inc. | 0.00% | Add +0.3% | 2,848,663 | $6.2M |
| Nantahala Capital Management, LLC | 0.40% | No change | 2,190,000 | $4.8M |
| Blackstone Inc. | 0.02% | No change | 2,070,684 | $4.5M |
| Stonepine Capital Management, LLC | 1.95% | Reduce -19.2% | 914,973 | $2.0M |
| Millennium Management | 0.00% | Add +542.4% | 913,502 | $2.0M |
| Susquehanna International Group, LLP | 0.00% | New | 504,625 | $1.1M |
| BlackRock, Inc. | 0.00% | Add +26.4% | 423,979 | $929K |
| Geode Capital Management, LLC | 0.00% | Add +0.6% | 324,760 | $711K |
| Goldman Sachs Group Inc. | 0.00% | Add +277.7% | 166,025 | $364K |
| Blair William & Co. | 0.00% | Add +15.6% | 155,953 | $342K |
| Marshall Wace, LLP | 0.00% | New | 155,270 | $340K |
| Jane Street Group, LLC | 0.00% | New | 116,249 | $255K |
| Barclays PLC | 0.00% | No change | 84,000 | $184K |
| Balyasny Asset Management L.P. | 0.00% | New | 81,161 | $178K |
| HRT Financial LP | 0.00% | Add +42.0% | 65,906 | $144K |
| Northern Trust Corp. | 0.00% | No change | 64,011 | $140K |
| OMERS ADMINISTRATION Corp | 0.00% | Add +2.6% | 56,000 | $123K |
| Jain Global LLC | 0.00% | New | 54,845 | $120K |
| UBS Group AG | 0.00% | Add +64.5% | 45,266 | $99K |
| Bank of America Corp. | 0.00% | Add +898.6% | 45,026 | $99K |
| State Street Corp. | 0.00% | No change | 41,884 | $92K |
| Qube Research & Technologies Ltd | 0.00% | New | 35,625 | $78K |
| ExodusPoint Capital Management, LP | 0.00% | New | 32,538 | $71K |
| LMR Partners LLP | 0.00% | New | 31,092 | $68K |
| Diametric Capital, LP | 0.07% | New | 28,366 | $62K |
| Y-Intercept (Hong Kong) Ltd | 0.00% | New | 26,775 | $59K |
| Citigroup Inc. | 0.00% | Reduce -66.6% | 25,765 | $56K |
| Morgan Stanley | 0.00% | Add +196.7% | 21,646 | $47K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 16,876 | $37K |
| Caxton Corp. | 0.71% | No change | 16,393 | $36K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | New | 14,976 | $33K |
| Jefferies Financial Group Inc. | 0.00% | No change | 14,800 | $32K |
| Catalyst Funds Management Pty Ltd | 0.01% | New | 13,712 | $30K |
| Stifel Financial Corp. | 0.00% | No change | 13,129 | $29K |
| Quantessence Capital LLC | 0.01% | New | 13,005 | $28K |
| Prelude Capital Management, LLC | 0.00% | New | 11,098 | $24K |
| Capstone Investment Advisors, LLC | 0.00% | New | 11,067 | $24K |
| Brevan Howard Capital Management LP | 0.00% | New | 10,384 | $23K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 9,043 | $20K |
| Point72 (DIFC) Ltd | 0.00% | New | 1,980 | $4K |
| Wells Fargo & Company | 0.00% | No change | 167 | $366 |
"% of holder's portfolio" is IKT's weight in each manager's 13F, not the share of Inhibikase Therapeutics Inc. the manager owns.